Excelya

Executive Summary

Excelya is a France-based contract research organization (CRO) founded in 2014, offering full-service, functional service provider (FSP), and resourcing solutions to biotech, pharma, and medical device companies. With a collaborative and flexible approach, Excelya supports clinical development across diverse therapeutic areas, aiming to accelerate the delivery of life-changing therapies. The company has built a reputation for expert-driven trial solutions, positioning itself as a trusted partner in the clinical research landscape. Despite being private and lacking disclosed financials, Excelya's focus on Europe and its scalable service model position it for steady growth within the competitive CRO market. The company's potential lies in expanding its client base and leveraging digital health capabilities to enhance trial efficiency. However, its limited profile and absence of recent public milestones suggest a need for greater visibility to attract larger partnerships.

Upcoming Catalysts (preview)

• 2026Announcement of strategic partnership or major contract win with a top pharma company40% success
• TBDLaunch of a new digital health or technology-enabled clinical trial service50% success
• 2027Expansion into a new geographic market (e.g., North America or Asia)30% success